The inhibition of terminal oxidation by porphyrinogenic drugs
- 1 November 1967
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 16 (11) , 2189-2199
- https://doi.org/10.1016/0006-2952(67)90018-4
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Urinary Excretion of Porphyrin Precursors and Coproporphyrin in Healthy Females on Oral ContraceptivesBMJ, 1966
- The role of succinyl-CoA synthetase in the control of heme biosynthesisBiochimica et Biophysica Acta (BBA) - General Subjects, 1965
- CONTRAINDICATIONS OF BIOLOGICAL-OXIDATION INHIBITORS IN THE TREATMENT OF PORPHYRIAThe Lancet, 1965
- ORAL CONTRACEPTIVES AND ACUTE INTERMITTENT PORPHYRIAThe Lancet, 1964
- Pasteur effect and the DPN-flavoprotein region of the respiratory chainBiochemical and Biophysical Research Communications, 1964
- The inhibition of cerebral NAD(P)H:(Acceptor) oxidoreductase by barbiturates and nervous depressants: Relationship with chemical sturcture relationship with chemical structureBiochimica et Biophysica Acta, 1963
- DISTURBANCE OF PORPHYRIN METABOLISM CAUSED BY GRISEOFULVIN IN MICE.British Journal of Dermatology, 1963
- Porphyria Induced in the Rabbit by Diethyl l,4‐dihydro‐2,4,6‐trimethylpyridine‐3,5‐dicarboxylate: I. Excretion of δ‐aminolaevulic Acid, Porphobilinogen, Coproporphyrin and ProtoporphyrinActa Pharmacologica et Toxicologica, 1961
- RELATIONSHIPS OF PYRUVATE AND LACTATE DURING ANAEROBIC METABOLISM. I. EFFECTS OF INFUSION OF PYRUVATE OR GLUCOSE AND OF HYPERVENTILATION1Journal of Clinical Investigation, 1958
- Studies on the electron transport systemBiochimica et Biophysica Acta, 1956